Skip to main content

Ankle Arthrodesis or Arthroplasty

0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Kuros Biosciences
Kuros BiosciencesSwitzerland - Schlieren
1 program
MagnetOsN/A2 trials
Active Trials
NCT07512336Not Yet Recruiting140Est. May 2030
NCT07225751Recruiting126Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
Kuros BiosciencesMagnetOs
Kuros BiosciencesMagnetOs

Clinical Trials (2)

Total enrollment: 266 patients across 2 trials

A Randomized Intra-Patient Controlled Trial of MagnetOs™ Putty vs Autograft in Instrumented Posterolateral Spinal Fusion in Idiopathic Scoliosis Patients

Start: May 2026Est. completion: May 2030140 patients
N/ANot Yet Recruiting

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Start: Nov 2025Est. completion: Dec 2028126 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 266 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.